辛伐他汀在原发性高血压和ACS的临床作用观察  

Observation on Simvastatin at the primary hypertension and the ACS clinical function

作　　者：陈清波[1] 

机构地区：[1]贵州省湄潭县人民医院内一科,贵州湄潭564100

出　　处：《中国当代医药》2009年第18期191-192,共2页China Modern Medicine

摘　　要：他汀类药物是治疗高胆固醇血症的首选药物已达成共识,但其在治疗具有高血压和急性冠脉综合征(ACS)高危因素的人群时更能稳定血压,降低主要的心血管事件,这与其独特的抗感染及改善血管内皮功能作用具有重要的关联性。Statins to treat hypercholesterolemia have reached a consensus on the preferred drug, but in the treatment of hypertension and acute coronary syndrome （ACS） with high-risk factors among more stable blood pressure, reduce major cardiovascular. With its unique anti-inflammatory and to improve vascular endothelial function has an important relevance.

关 键 词：辛伐他汀 原发性高血压 ACS 临床作用 

分 类 号：R541.4[医药卫生—心血管疾病]